BIOGEN INC.
BIIBUS売上高
$9.9B
百万USD
営業利益
-
百万USD
純利益
$1.3B
百万USD
ROE
-
最新FY
EPS
$8.79
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $2.7B | $410M | $2.69 |
| FY2021 | Q2 | $2.8B | $449M | $2.99 |
| FY2021 | Q3 | $2.8B | $329M | $2.22 |
| FY2021 | FY | $11.0B | $1.6B | $10.40 |
| FY2022 | Q1 | $2.6B | $1.1B | $7.24 |
| FY2022 | Q3 | $2.5B | $1.1B | $7.84 |
| FY2022 | FY | $10.2B | $3.0B | $20.87 |
| FY2023 | Q1 | $2.5B | $388M | $2.67 |
| FY2023 | Q2 | $2.5B | $592M | $4.07 |
| FY2023 | Q3 | $2.5B | $-68M | $-0.47 |
| FY2023 | FY | $9.8B | $1.2B | $7.97 |
| FY2024 | Q1 | $2.3B | $393M | $2.70 |
| FY2024 | Q2 | $2.5B | $584M | $4.00 |
| FY2024 | Q3 | $2.5B | $389M | $2.66 |
| FY2024 | FY | $9.7B | $1.6B | $11.18 |
| FY2025 | Q1 | $2.4B | $241M | $1.64 |
| FY2025 | Q2 | $2.6B | $635M | $4.33 |
| FY2025 | Q3 | $2.5B | $467M | $3.17 |
| FY2025 | FY | $9.9B | $1.3B | $8.79 |
| FY2026 | Q1 | $2.5B | $320M | $2.15 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | $11.4B | $12.3B | $13.5B | $14.4B | $13.4B | $11.0B | $10.2B | $9.8B | $9.7B | $9.9B |
| 営業利益 | $5.2B | $5.3B | $5.9B | $7.0B | $4.6B | $2.8B | - | - | - | - |
| 純利益 | $3.7B | $2.5B | $4.4B | $5.9B | $4.0B | $1.6B | $3.0B | $1.2B | $1.6B | $1.3B |
| 総資産 | $22.9B | $23.7B | $25.3B | $27.2B | $24.6B | $23.9B | $24.6B | $26.8B | $28.0B | $29.4B |
| 純資産 | $12.1B | $12.6B | $13.0B | $13.3B | $10.7B | $11.0B | $13.4B | $14.8B | $16.7B | $18.3B |
| 自己資本 | $12.1B | $12.6B | $13.0B | $13.3B | $10.7B | $10.9B | $13.4B | $14.8B | - | - |
| 営業CF | $4.5B | $4.6B | $6.2B | $7.1B | $4.2B | $3.6B | $1.4B | $1.5B | $2.9B | $2.2B |
| EPS | $16.93 | $11.92 | $21.58 | $31.42 | $24.80 | $10.40 | $20.87 | $7.97 | $11.18 | $8.79 |
| BPS | $56.22 | $59.62 | $66.29 | $76.66 | $70.24 | $74.14 | $92.73 | $101.81 | - | - |
| ROE | 30.5% | 20.1% | 34.0% | 44.1% | 37.4% | 14.3% | 22.7% | 7.8% | - | - |